Patients undergoing transcatheter aortic valve implantation (TAVI) frequently have coronary artery disease requiring percutaneous coronary intervention (PCI). Usually, PCI and TAVI are performed in two separate procedures and current studies are investigating potential benefits regarding the order. However, the two interventions may also be performed simultaneously, thereby limiting the risk associated with repeated vascular access. Data evaluating benefit and harm of concomitant procedures are scarce.

中文翻译：

---

经导管主动脉瓣植入术患者的同步经皮冠状动脉介入治疗

接受经导管主动脉瓣植入术 (TAVI) 的患者经常患有需要经皮冠状动脉介入治疗 (PCI) 的冠状动脉疾病。通常，PCI 和 TAVI 是在两个单独的程序中进行的，目前的研究正在调查该顺序的潜在好处。然而，两种干预措施也可以同时进行，从而限制与重复血管通路相关的风险。评估伴随手术的益处和危害的数据很少。